ストックスクリーナーアプリを入手
2.72
9.03%
-0.27
前日終値:
$2.99
開ける：
$2.95
24時間の取引高:
2.93M
Relative Volume:
1.30
時価総額：
$525.52M
収益：
$25.55M
当期純損益:
$-341.97M
株価収益率:
-0.9714
EPS:
-2.8
ネットキャッシュフロー:
$-304.44M
1週間 パフォーマンス:
-11.11%
1か月 パフォーマンス:
-16.31%
6か月 パフォーマンス:
-63.54%
1年 パフォーマンス:
-67.23%
1日の値動き範囲:
$2.69
$2.97
1週間の範囲:
$2.69
$3.155
52週間の値動き範囲:
$2.69
$10.72
Relay Therapeutics Inc Stock (RLAY) Company Profile
RLAY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
2.72 | 525.52M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-10 | 再開されました | Goldman | Buy |
| 2024-09-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-09-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-05-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-04-20 | アップグレード | Jefferies | Underperform → Hold |
| 2023-04-19 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 開始されました | Raymond James | Outperform |
| 2023-02-03 | 開始されました | Oppenheimer | Outperform |
| 2022-09-30 | 開始されました | Barclays | Equal Weight |
| 2022-09-02 | 開始されました | Stifel | Buy |
| 2022-06-06 | 開始されました | Jefferies | Underperform |
| 2022-02-01 | 開始されました | Berenberg | Buy |
| 2021-07-21 | 開始されました | BofA Securities | Buy |
| 2020-12-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-08 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-11-05 | 開始されました | H.C. Wainwright | Buy |
| 2020-08-10 | 開始されました | Cowen | Outperform |
| 2020-08-10 | 開始されました | Goldman | Buy |
| 2020-08-10 | 開始されました | Guggenheim | Buy |
| 2020-08-10 | 開始されました | JP Morgan | Neutral |
すべてを表示
Relay Therapeutics Inc (RLAY) 最新ニュース
Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Purchased by HighTower Advisors LLC - Defense World
Charles Schwab Investment Management Inc. Decreases Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Relay Therapeutics stock hits 52-week low at $3.01 amid market challenges - Investing.com India
Bank of New York Mellon Corp Buys 50,190 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Investor Alert: What’s Really Going On At Relay Therapeutics Inc (NASDAQ: RLAY) - Stocks Register
Victory Capital Management Inc. Has $63,000 Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Steward Partners Investment Advisory LLC Purchases 4,000 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Head-To-Head Contrast: Relay Therapeutics (NASDAQ:RLAY) & Kyverna Therapeutics (NASDAQ:KYTX) - Defense World
Relay Therapeutics’ SWOT analysis: promising drug faces stiff competition By Investing.com - Investing.com South Africa
Relay Therapeutics’ SWOT analysis: promising drug faces stiff competition - Investing.com India
Arizona State Retirement System Acquires 7,547 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics’ SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa
Relay Therapeutics’ SWOT analysis: stock poised for growth amid challenges - Investing.com
Relay Therapeutics’ (RLAY) Buy Rating Reiterated at HC Wainwright - Armenian Reporter
HC Wainwright Reiterates “Buy” Rating for Relay Therapeutics (NASDAQ:RLAY) - Defense World
Rhumbline Advisers Acquires 13,532 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
New York State Common Retirement Fund Has $121,000 Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Down -31.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Relay Therapeutics (RLAY) - Yahoo Finance
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
The Goldman Sachs Group Lowers Relay Therapeutics (NASDAQ:RLAY) Price Target to $18.00 - Defense World
Stifel Nicolaus Issues Pessimistic Forecast for Relay Therapeutics (NASDAQ:RLAY) Stock Price - Defense World
Relay Therapeutics (NASDAQ:RLAY) Sets New 1-Year Low After Analyst Downgrade - Defense World
Relay Therapeutics price target lowered to $12 from $21 at Citizens JMP - TipRanks
Relay Therapeutics stock target cut to $12 at Citizens JMP - Investing.com
Buy Rating for Relay Therapeutics Driven by Strategic Advancements and Promising Clinical Trial Developments - TipRanks
RLAY stock touches 52-week low at $3.34 amid market challenges - Investing.com
Relay Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Relay Therapeutics Reports 2024 Financial Results and Progress - TipRanks
Relay Therapeutics reports Q4 EPS (45c), consensus (55c) - TipRanks
Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates - The Manila Times
Relay Therapeutics, Inc. SEC 10-K Report - TradingView
What To Expect From Relay Therapeutics Inc (RLAY) Q4 2024 Earnin - GuruFocus.com
What To Expect From Relay Therapeutics Inc (RLAY) Q4 2024 Earnings - Yahoo Finance
Relay Therapeutics to Participate in Two Upcoming Investor Conferences - WICZ
Can These Two Major Healthcare Conferences Reveal Relay Therapeutics' Next Big Move? - StockTitan
Relay Therapeutics (RLAY) to Release Earnings on Wednesday - MarketBeat
Savant Capital LLC Buys Shares of 29,088 Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World
Relay Therapeutics (RLAY) Projected to Post Quarterly Earnings on Thursday - Defense World
Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025 - The Manila Times
The Potential Rise in the Price of Relay Therapeutics Inc (RLAY) following insiders activity - Knox Daily
Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Nasdaq
Relay Therapeutics to Announce Fourth Quarter and Full Year - GlobeNewswire
Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and ... - The Bakersfield Californian
This Insider Has Just Sold Shares In Relay Therapeutics - Simply Wall St
Relay Therapeutics CEO Sanjiv Patel sells $818,399 in stock - MSN
Relay Therapeutics (NASDAQ:RLAY) Shares Gap DownTime to Sell? - MarketBeat
Relay Therapeutics Inc (RLAY) 財務データ
収益
当期純利益
現金流量
EPS
Relay Therapeutics Inc (RLAY) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv | President and CEO |
Feb 11 '25 |
Sale |
3.85 |
140,182 |
539,701 |
625,948 |
| Patel Sanjiv | President and CEO |
Feb 13 '25 |
Sale |
3.70 |
75,324 |
278,699 |
883,089 |
| Rahmer Peter | See remarks |
Jan 29 '25 |
Sale |
4.55 |
26,541 |
120,762 |
419,681 |
| Rahmer Peter | See remarks |
Jan 30 '25 |
Sale |
4.42 |
17,250 |
76,245 |
402,431 |
| Rahmer Peter | See remarks |
Jan 28 '25 |
Sale |
4.63 |
1,673 |
7,746 |
307,081 |
| Catinazzo Thomas | Chief Financial Officer |
Jan 28 '25 |
Sale |
4.63 |
36,036 |
166,847 |
263,190 |
| Catinazzo Thomas | Chief Financial Officer |
Jan 30 '25 |
Sale |
4.42 |
20,791 |
91,896 |
379,431 |
| Catinazzo Thomas | Chief Financial Officer |
Jan 29 '25 |
Sale |
4.55 |
2,109 |
9,596 |
400,222 |
| Bergstrom Donald A | President, R&D |
Jan 29 '25 |
Sale |
4.55 |
46,407 |
211,152 |
646,861 |
| Bergstrom Donald A | President, R&D |
Jan 30 '25 |
Sale |
4.42 |
30,823 |
136,238 |
616,038 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):